Question

A client who is prescribed terbutaline (Brethine) 0.25 mg subcutaneously. Which of the following is an adverse effect of this medication?

a) Hypertension
b) Hyperkalemia
c) Tachycardia
d) Respiratory depression

Answer 1

The adverse effect of terbutaline (Brethine) 0.25 mg subcutaneously is tachycardia, which is a rapid heart rate.

Step-by-step explanation:

The adverse effect of terbutaline (Brethine) 0.25 mg subcutaneously is tachycardia, which is a rapid heart rate. Terbutaline is a beta-2 adrenergic agonist, which means it stimulates the beta-2 receptors in the body, including those in the heart. The stimulation of these receptors leads to an increase in heart rate.